MAI network supplier
바이오 의약품, 바이러스 벡터 및 백신의 개발 및 제조 경험을 갖춘 신뢰할 수 있는 CDMO 파트너입니다.
등록 후 이용 가능 위치
MAI network supplier
—
등록 후 이용 가능 위치
MAI network supplier
엔드투엔드 제약 CDMO
등록 후 이용 가능 위치
이러한 시설은 기본 기준과 일치하지만 모든 선택적 필터와 일치하지는 않습니다.
Category / Product: SERVICES, FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC
Region: Europe

Category / Product: COSMETICS, 분석 CRO, FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC
Batch Size: Large, Medium
Markets: EMA (EU)
Compliance: ISO, EMA (EU GMP)
Services: Development services, Analytical / QC services, Logistics, Manufacturing services, Quality Assurance services, Regulatory services, Packaging
Use: Human, Veterinary
Therapeutic Areas of Expertise (ATC): (S) Sensory organs, (R) Respiratory system
Region: Europe

Category / Product: COSMETICS, 분석 CRO, FDF / DRUG PRODUCTS
Batch Size: Large, Medium
Markets: EMA (EU), MHRA (UK), EDE (UAE), SFDA (Saudi Arabia)
Compliance: ISO
Services: Development services, Analytical / QC services, Logistics, Manufacturing services, Quality Assurance services, Regulatory services, Packaging
Use: Human
Region: Europe
Batch Size: Large, Medium
Compliance: TITCK (Turkish Health Authorities), ANVISA (Brazil B-GMP), FDA (cGMP), TGA (Australia GMP), Roszdravnadzor (Russia GMP), EMA (EU GMP)
Markets: EMA (EU), Russian Health Authorities, FDA (USA), ANVISA (Brazil), TGA (Australia)
Use: Human, Veterinary
Therapeutic Areas of Expertise (ATC): (S) Sensory organs
Category / Product: 분석 CRO, FDF / DRUG PRODUCTS
Region: Europe

Batch Size: Large, Small, Medium
Compliance: TITCK (Turkish Health Authorities), ANVISA (Brazil B-GMP), COFEPRIS, ISO, ICH, FDA (cGMP), PMDA/MHLW (Japan GMP), Health Canada (Canada GMP), MHRA (UK GMP), ANMAT (Argentina nueva GMP), TGA (Australia GMP), Roszdravnadzor (Russia GMP), ECOVADIS, ISP (Chile BPM), French Service-Public (CIR), World Health Organization (GMP / HACCP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP), UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority)
Markets: EMA (EU), MHRA (UK), INVIMA (Colombia), MSPAS (Guatemala), Russian Health Authorities, FDA (USA), PMDA (Japan), Health Canada (Canada), ANMAT (Argentina), 나머지 세계, COFEPRIS (Mexico), EDE (UAE), ISP (Chile), ANVISA (Brazil), DIGEMID (Peru), Turkish Health Authorities, MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia)
Services: Development services, Analytical / QC services, Manufacturing services, Quality Assurance services
Use: Human, Veterinary
Therapeutic Areas of Expertise (ATC): (B) Blood and blood forming organs, (D) Dermatologicals, (N) Nervous system, (J) Antiinfectives for systemic use, (R) Respiratory system, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (H) Systemic hormonal preparations excl. sex hormones and insulins, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism
Region: Europe
Category / Product: BIOLOGICS

53Biologics
53Biologics는 전임상 단계부터 상업적 공급 단계까지 계속해서 발전할 수 있는 엔드투엔드 생물학적 제제 CDMO 도구입니다. 우리는 이것을 위해 만들어졌습니다.
Batch Size: Large, Small, Medium
BSL (Biological Safety Level): 1, 2
Compliance: ISO, FDA (cGMP), World Health Organization (GMP / HACCP), EMA (EU GMP)
Markets: FDA (USA), Health Canada (Canada), ANMAT (Argentina), COFEPRIS (Mexico), ISP (Chile), ANVISA (Brazil), DIGEMID (Peru), MSPAS (Guatemala), INVIMA (Colombia), MHRA (UK), EMA (EU), TGA (Australia)
Services: Development services, Analytical / QC services, Logistics, Manufacturing services, Quality Assurance services, Regulatory services
Use: Human, Veterinary
Region: Europe
Category / Product: BIOLOGICS

Markets: EMA (EU)
Services: Development services, Regulatory services
Therapeutic Areas of Expertise (ATC): (V04) Diagnostic agents, (D) Dermatologicals, (J) Antiinfectives for systemic use, (B) Blood and blood forming organs, (V09-10) Radiopharmaceuticals, (N) Nervous system, (S) Sensory organs, (V06) Nutrients, (V01) Allergens, (R) Respiratory system, (P) Antiparasitic products, insecticides and repellents, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (H) Systemic hormonal preparations excl. sex hormones and insulins, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism
Category / Product: 임상 CRO, SERVICES
Use: Human
Region: Europe

Bilthoven Biologicals BV
원료의약품 및 완제의약품에 대한 다중 제품 GMP 시설.
Markets: EMA (EU), MHRA (UK)
Batch Size: Large, Small, Medium
BSL (Biological Safety Level): 1, 2
Services: Development services, Logistics, Analytical / QC services, Manufacturing services, Quality Assurance services, Regulatory services, Packaging
Use: Human
Compliance: EMA (EU GMP)
Category / Product: FDF / DRUG PRODUCTS, 분석 CRO, BIOLOGICS
Region: Europe

Polpharma API
Integrated CDMO solutions for HP APIs (OEB 6), ADC payload-linkers and oligonucleotides from development to GMP supply.
Compliance: BRCGS, ISO, ICH, FDA (cGMP), DIGEMID, ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, Roszdravnadzor (Russia GMP), IFS, Halal Research Council, PMDA/MHLW (Japan GMP), TGA (Australia GMP), INVIMA, ECOVADIS, ISP (Chile BPM), TITCK (Turkish Health Authorities), French Service-Public (CIR), ANMAT (Argentina nueva GMP), EMA (EU GMP), NMPA (China GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP), SQF (Safe Quality Food), NSF, UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority)
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China), Health Canada (Canada), MHRA (UK), MFDS (South Korea)
Batch Size: Large, Small, Medium
Services: Development services, Analytical / QC services, Manufacturing services, Quality Assurance services, Regulatory services
Therapeutic Areas of Expertise (ATC): (N) Nervous system, (B) Blood and blood forming organs, (D) Dermatologicals, (J) Antiinfectives for systemic use, (M) Musculoskeletal system, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism
Category / Product: PARTICLE ENGINEERING, SERVICES, CHEMICAL-SYNTHETIC, OLIGONUCLEOTIDES
Use: Human
OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)
Region: Europe
Are you a pharmaceutical company seeking a reliable CMO or CDMO partner to accelerate your drug development process? Look no further than MAI CDMO Network. Our advanced search platform connects you with a vast network of qualified contract manufacturers and development organizations worldwide.
Why Choose MAI CDMO Network?
How MAI CDMO Network Works
Key Benefits of Partnering with a CMO/CDMO
Featured Services
Ready to Find Your Ideal CMO/CDMO Partner? Register Now
Explore our platform today and discover how MAI CDMO Network can help you achieve your drug development goals.